Hyalinizing trabecular tumor and papillary carcinoma of the thyroid

Chinese Medical Journal

Volumn 123, Issue 20, 2010, Pages 2832-2835

  Zhu, Hong ^a   Qi, Ji Ping ^a   Wang, Ying Wei ^a   Song, Yue Jia ^a   Zhang, Zhi Yi ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Hyalinizing trabecular tumors; Immunohistochemistry; Papillary carcinoma; Pathological features

Indexed keywords

CYTOKERATIN 19; GALECTIN 3; KI 67 ANTIGEN; HBME 1 ANTIGEN; HBME-1 ANTIGEN; MIB1 PROTEIN, HUMAN; TUMOR MARKER; UBIQUITIN PROTEIN LIGASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN EXPRESSION; SCHOOL CHILD; THYROID HYALINIZING TRABECULAR TUMOR; THYROID PAPILLARY CARCINOMA; THYROID TUMOR; CHEMISTRY; MIDDLE AGED; PAPILLARY CARCINOMA;

ADOLESCENT; ADULT; AGED; CARCINOMA, PAPILLARY; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; GALECTIN 3; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-19; MALE; MIDDLE AGED; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UBIQUITIN-PROTEIN LIGASES;

EID: 79952279285     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.20.016     Document Type: Article

References (23)

1. Carney JA, Ryan J, Goellner JR. Hyalinizing trabecular adenoma of the thyroid gland. Am J Surg Pathol 1987; 11: 583-591.
2. Evenson A, Mowschenson P, Wang H, Connolly J, Mendrinos S, Parangi S, et al. Hyalinizing trabecular adenoma-an uncommon thyroid tumor frequently misdiagnosed as papillary or medullary thyroid carcinoma. Am J Surg 2007; 193: 707-712.
3. McCluggage WG, Sloan JM. Hyalinizing trabecular carcinoma of thyroid gland. Histopathology 1996; 28: 357-362.
4. Molberg K, Albores-Saavedra J. Hyalinizing trabecular carcinoma of the thyroid gland. Hum Pathol 1994; 25: 192-197.
5. Papotti M, Riella P, Montemurro F, Pietribiasi F, Bussolati G. Immunophenotypic heterogeneity of hyalinizing trabecular tumours of the thyroid. Histopathology 1997; 31: 525-533.
6. Cheung CC, Boerner SL, MacMillan CM, Ramyar L, Asa SL. Hyalinizing trabecular tumor of the thyroid: a variant of papillary carcinoma proved by molecular genetics. Am J Surg Pathol 2000; 24: 1622-1626.
7. Cerasoli S, Tabarri B, Farabegoli P, Vascotto L, Lanzanova G, Pasquinelli GA, et al. Hyalinizing trabecular adenoma of the thyroid. Report of two cases, with cytologic, immunohistochemical and ultrastructural studies. Tumori 1992; 78: 274-279.
8. Carney JA. Hyalinizing trabecular tumors of the thyroid gland: quadruply described but not by the discoverer. Am J Surg Pathol 2008; 32: 622-634.
9. Kuma S, Hirokawa M, Miyauchi A, Kakudo K, Katayama S. Cytologic features of hyalinizing trabecular adenoma of the thyroid. Acta Cytol 2003; 47: 399-404.
10. Rothenberg HJ, Goellner JR, Carney JA. Hyalinizing trabecular adenoma of the thyroid gland: recognition and characterization of its cytoplasmic yellow body. Am J Surg Pathol 1999; 23: 118-125.
11. Rothenberg HJ, Goellner JR, Carney JA. Prevalence and incidence of cytoplasmic yellow bodies in thyroid neoplasms. Arch Pathol Lab Med 2003; 127: 715-717.
12. Ohtsuki Y, Kimura M, Murao S, Okada Y, Teratani Y, Matsumoto M, et al. Immunohistochemical and electron microscopy studies of a case of hyalinizing trabecular tumor of the thyroid gland, with special consideration of the hyalinizing mass associated with it. Med Mol Morphol 2009; 42: 189-194.
13. Fonseca E, Nesland JM, Sobrinho-Simoes M. Expression of stratified epithelial-type cytokeratins in hyalinizing trabecular adenomas supports their relationship with papillary carcinomas of the thyroid. Histopathology 1997; 31: 330-335.
14. Salvatore G, Chiappetta G, Nikiforov YE, Decaussin-Petrucci M, Fusco A, Carney JA, et al. Molecular profile of hyalinizing trabecular tumours of the thyroid: high prevalence of RET/PTC rearrangements and absence of B-raf and N-ras point mutations. Eur J Cancer 2005; 41: 816-821.
15. Hirokawa M, Carney JA, Ohtsuki Y. Hyalinizing trabecular adenoma and papillary carcinoma of the thyroid gland express different cytokeratin patterns. Am J Surg Pathol 2000; 24: 877-881.
16. Leonardo E, Volante M, Barbareschi M, Cavazza A, Dei Tos AP, Bussolati G, et al. Cell membrane reactivity of MIB-1 antibody to Ki67 in human tumors: fact or artifact? Appl Immunohistochem Mol Morphol 2007; 15: 220-223.
17. Hirokawa M, Carney JA. Cell membrane and cytoplasmic staining for MIB-1 in hyalinizing trabecular adenoma of the thyroid gland. Am J Surg Pathol 2000; 24: 575-578.
18. Erkilic S, Kocer NE. The role of cytokeratin 19 in the differential diagnosis of true papillary carcinoma of thyroid and papillary carcinoma-like changes in Graves' disease. Endocr Pathol 2005; 16: 63-66.
19. Nga ME, Lim GS, Soh CH, Kumarasinghe MP. HBME-1 and CK19 are highly discriminatory in the cytological diagnosis of papillary thyroid carcinoma, Diagn Cytopathol 2008; 36: 550-556.
20. Gaffney RL, Carney JA, Sebo TJ, Erickson LA, Volante M, Papotti M, et al. Galectin-3 expression in hyalinizing trabecular tumors of the thyroid gland. Am J Surg Pathol 2003; 27: 494-498.
21. Torregrossa L, Faviana P, Camacci T, Materazzi G, Berti P, Minuto M, et al. Galectin-3 is highly expressed in nonencapsulated papillary thyroid carcinoma but weakly expressed in encapsulated type: comparison with Hector Battifora mesothelial cell 1 immunoreactivity. Hum Pathol 2007; 38: 1482-1488.
22. Miettinen M, Karkkainen P. Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours. Preferential reactivity with malignant tumours. Virchows Arch 1996; 429: 213-219.
23. de Matos PS, Ferreira AP, de Oliveira Facuri F, Assumpcao LV, Metze K, Ward LS. Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy. Histopathology 2005; 47: 391-401.